What Are The Considerations For Handling A Drug Product With Ultra-Low Temperature Requirements?

Cell and gene therapies are transforming treatment possibilities, but their success depends on maintaining product integrity throughout an increasingly complex supply chain. For Advanced Therapy Medicinal Products (ATMPs) requiring ultra-low temperature storage, even minor deviations can impact product viability, making careful planning and execution essential from packaging through distribution.

Successful handling begins with a detailed understanding of a product's temperature requirements and operational constraints. Key considerations include allowable time out of condition, conditioning requirements between environments, packaging material selection, label design, serialization needs and final pack configuration. Equally important are process validation activities that confirm packaging and handling procedures can consistently maintain required temperature conditions throughout the product journey.

Collaboration between manufacturers and experienced supply chain partners can help identify potential risks early, establish robust handling processes and support global distribution requirements. By taking a proactive approach to validation and planning, organizations can better prepare for the unique challenges associated with ultra-low temperature therapies and ensure products reach patients safely and efficiently.